Novartis
(NYSE) NVS
Novartis Financials at a Glance
Market Cap
$280.77B
Revenue (TTM)
$56.05B
Net Income (TTM)
$13.53B
EPS (TTM)
$7.02
P/E Ratio
21.72
Dividend
$4.74
Beta (Volatility)
0.33 (Low)
Dividend
$4.74
Beta (Volatility)
0.33 (Low)
Price
$153.30
Volume
7,223,536.507
Open
$154.20
Price
$153.30
Volume
7,223,536.507
Open
$154.20
Previous Close
$153.12
Daily Range
$152.31 - $154.96
52-Week Range
$112.34 - $170.46
Estimated Earnings Date
Apr 28, 2026
Dividend
$4.74
Beta (Volatility)
0.33 (Low)
Price
$153.30
Volume
7,223,536.507
Open
$154.20
Previous Close
$153.12
Daily Range
$152.31 - $154.96
52-Week Range
$112.34 - $170.46
Estimated Earnings Date
Apr 28, 2026
NVS News
NVS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Novartis
Industry
Pharmaceuticals
Sector
Health CareEmployees
75,267
CEO
Vasant Narasimhan, MD
Website
www.novartis.comHeadquarters
Basel, BS 4056, CH
NVS Financials
Key Financial Metrics (TTM)
Gross Margin
75.13%
Operating Margin
29.88%
Net Income Margin
24.31%
Return on Equity
31.54%
Return on Capital
20.53%
Return on Assets
11.34%
Earnings Yield
4.60%
Dividend Yield
3.09%
Payout Ratio
61.00%
Stock Overview
Market Cap
$280.77B
Shares Outstanding
1.83B
Volume
7.22M
Avg. Volume
1.53M
Financials (TTM)
Gross Profit
$42.19B
Operating Income
$17.12B
EBITDA
$22.40B
Operating Cash Flow
$19.16B
Capital Expenditure
-$2.81B
Free Cash Flow
$16.36B
Cash & ST Invst.
$6.98B
Total Debt
$47.00B
Novartis Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$13.52B
-0.7%
Gross Profit
$10.07B
-3.2%
Gross Margin
74.42%
N/A
Market Cap
$280.77B
N/A
Market Cap/Employee
$3.72M
N/A
Employees
75,511
N/A
Net Income
$3.16B
-12.5%
EBITDA
$5.41B
-7.2%
Quarterly Fundamentals
Total Cash
$6.98B
-3.0%
Total Debt
$47.00B
+50.3%
Accounts Receivable
$9.60B
+10.1%
Inventory
$6.29B
+7.8%
Long Term Debt
$39.11B
+68.4%
Short Term Debt
$7.89B
-1.9%
Return on Assets
11.34%
N/A
Return on Invested Capital
18.96%
N/A
Free Cash Flow
$2.87B
+33.4%
Operating Cash Flow
$3.68B
+0.9%